March 05, 2014
Novartis Pharmaceuticals Corp. filed a patent infringement lawsuit in New Jersey federal court Monday against Pharmaceuticals International Inc., alleging the Hunt Valley, Md.-based drugmaker is infringing on Novartis' patent for the cancer drug Zometa by trying to manufacture a generic version.